Ondansetron in multiple sclerosis.
Two young women with chronic nausea and vertigo caused by multiple sclerosis responded to the introduction and maintenance of the 5HT3 receptor antagonist, ondansetron. Palliative care is a neglected aspect of management of degenerative neurological diseases and these cases highlight the approaches that may be used to manage difficult symptoms in the population with multiple sclerosis.
Macleod
A D
AD
Psychiatric Consultation Services, Christchurch Hospital, Christchurch, New Zealand.
D000328:Adult; D005260:Female; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications*; D009325:Nausea / Q000188:drug therapy* / Q000209:etiology*; D017294:Ondansetron / Q000627:therapeutic use*; D010166:Palliative Care; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D016896:Treatment Outcome; D014717:Vertigo / Q000188:drug therapy* / Q000209:etiology*
D012702:Serotonin Antagonists; D017294:Ondansetron